Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in “pan-negative” lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history.
Alexander E. Drilon
No relevant relationships to disclose
Lu Wang
No relevant relationships to disclose
Maria E. Arcila
No relevant relationships to disclose
Eun Jung Cho
No relevant relationships to disclose
Sohail Balasubramanian
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Joel R. Greenbowe
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Jeffrey S. Ross
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Phil Stephens
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Doron Lipson
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Vincent A. Miller
Employment or Leadership Position - Foundation Medicine
Stock Ownership - Foundation Medicine
Mark G. Kris
No relevant relationships to disclose
Marc Ladanyi
Stock Ownership - Foundation Medicine
Naiyer A. Rizvi
No relevant relationships to disclose